Related Experiment Video
Updated: Jan 15, 2026

07:20
Inducement and Evaluation of a Murine Model of Experimental Myopia
Published on: January 22, 2019
10.5K
An innovative diagnostic method for myopia using blood-based biomemristor
Zhirong Liu1, Xiaobin Ren2, Bai Sun2,3
1Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, Shaanxi, 710004, China.
Materials Today. Bio
|October 13, 2025
Summary
A novel memristive device using ZIF-8 detects high myopia by analyzing physiological indicators in blood samples. This breakthrough offers hope for early myopia screening and monitoring in adolescents.
Area of Science:
- Materials Science
- Biomedical Engineering
- Ophthalmology
Background:
- Adolescent myopia is a growing health concern with limited diagnostic methods based on physiological indicators.
- Current diagnostic approaches for myopia lack the sensitivity to detect subtle physiological changes.
Purpose of the Study:
- To develop a novel memristive device for detecting and distinguishing physiological states associated with high myopia.
- To investigate the potential of ZIF-8 based memristors for early myopia screening and monitoring.
Main Methods:
- Fabrication of a memristive device with Ag/ZIF-8:PVP/FTO structure using ZIF-8 as the functional material.
- Characterization of the memristor's electrical properties, including I-V curves and resistance switching behavior.
- Testing the biomemristor with blood samples from highly myopic patients and analyzing memristive behavior in a twin study.
Main Results:
- The ZIF-8 based memristor demonstrated significant memristive characteristics and stable bipolar resistance switching.
- Optimized device achieved robust multi-level switching, with atypical memory blockade observed in myopic patients' blood samples.
- Altered memristive behavior correlated with phenotypic differences, not genetic identity, indicating sensitivity to physiological changes.
Conclusions:
- This study presents the first application of ZIF-8 memristors for myopia detection, offering a new avenue for early screening.
- The developed biomemristor shows promise for phenotype stratification and minimally invasive monitoring in pediatric and high-risk populations.
- The device's sensitivity to physiological changes highlights its potential for personalized myopia management.

